ZA906057B - 4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents - Google Patents
4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agentsInfo
- Publication number
- ZA906057B ZA906057B ZA906057A ZA906057A ZA906057B ZA 906057 B ZA906057 B ZA 906057B ZA 906057 A ZA906057 A ZA 906057A ZA 906057 A ZA906057 A ZA 906057A ZA 906057 B ZA906057 B ZA 906057B
- Authority
- ZA
- South Africa
- Prior art keywords
- thioureas
- ureas
- butynyl
- derivatives
- substituted amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/02—Thiourea
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/388,785 US4988688A (en) | 1989-08-02 | 1989-08-02 | 4-(N-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA906057B true ZA906057B (en) | 1992-04-29 |
Family
ID=23535507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA906057A ZA906057B (en) | 1989-08-02 | 1990-08-01 | 4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4988688A (fi) |
| EP (1) | EP0411615B1 (fi) |
| JP (1) | JPH0374359A (fi) |
| KR (1) | KR910004559A (fi) |
| AT (1) | ATE99290T1 (fi) |
| AU (1) | AU6001990A (fi) |
| CA (1) | CA2022510A1 (fi) |
| DE (1) | DE69005557T2 (fi) |
| DK (1) | DK0411615T3 (fi) |
| ES (1) | ES2062220T3 (fi) |
| FI (1) | FI903835A7 (fi) |
| IE (1) | IE902792A1 (fi) |
| NO (1) | NO903384L (fi) |
| PT (1) | PT94874A (fi) |
| ZA (1) | ZA906057B (fi) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5202459A (en) * | 1989-11-07 | 1993-04-13 | Nippon Kayaku Kabushiki Kaisha | Process for producing cyclobutane derivative |
| US5182284A (en) * | 1990-01-26 | 1993-01-26 | Taiho Pharmaceutical Co., Ltd. | Piperazine compounds, processes for preparation thereof and medical uses thereof |
| FR2677019B1 (fr) * | 1991-05-27 | 1994-11-25 | Pf Medicament | Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique. |
| US6225305B1 (en) | 1993-10-04 | 2001-05-01 | Glaxo Wellcome Inc. | Substituted urea and isothiorea derivatives as no synthase inhibitors |
| US6090846A (en) * | 1994-06-01 | 2000-07-18 | Glaxo Wellcome Inc. | Substituted urea and isothiourea derivatives as no synthase inhibitors |
| AU7705694A (en) * | 1993-10-04 | 1995-05-01 | Glaxo Wellcome House | Substituted urea and isothiourea derivatives as no synthase inhibitors |
| US6297276B1 (en) | 1993-10-04 | 2001-10-02 | Glaxosmithkline | Substituted urea and isothiourea derivatives as no synthase inhibitors |
| GB9418912D0 (en) * | 1994-09-20 | 1994-11-09 | Fisons Corp | Pharmaceutically active compounds |
| TW397812B (en) * | 1995-02-11 | 2000-07-11 | Astra Ab | Bicyclic isothiourea derivatives useful in therapy |
| US6313172B1 (en) * | 2000-04-13 | 2001-11-06 | Allergan Sales, Inc. | Methods and compositions for modulating alpha adrenergic receptor activity |
| US6545182B2 (en) * | 2000-04-13 | 2003-04-08 | Allergan Sales, Inc. | Methods and compositions for modulating alpha adrenergic receptor activity |
| US7185522B2 (en) | 2005-05-10 | 2007-03-06 | T. Sendzimir, Inc. | Side supported 6-high rolling mill |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3354178A (en) * | 1965-04-09 | 1967-11-21 | Sterling Drug Inc | Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides |
| US4065471A (en) * | 1965-04-09 | 1977-12-27 | Sterling Drug Inc. | N-(4-Amino-2-butynyl)imides |
-
1989
- 1989-08-02 US US07/388,785 patent/US4988688A/en not_active Expired - Fee Related
-
1990
- 1990-07-31 AU AU60019/90A patent/AU6001990A/en not_active Abandoned
- 1990-08-01 AT AT90114787T patent/ATE99290T1/de not_active IP Right Cessation
- 1990-08-01 CA CA002022510A patent/CA2022510A1/en not_active Abandoned
- 1990-08-01 DK DK90114787.6T patent/DK0411615T3/da active
- 1990-08-01 FI FI903835A patent/FI903835A7/fi not_active Application Discontinuation
- 1990-08-01 NO NO90903384A patent/NO903384L/no unknown
- 1990-08-01 IE IE279290A patent/IE902792A1/en unknown
- 1990-08-01 ES ES90114787T patent/ES2062220T3/es not_active Expired - Lifetime
- 1990-08-01 ZA ZA906057A patent/ZA906057B/xx unknown
- 1990-08-01 JP JP2202622A patent/JPH0374359A/ja active Pending
- 1990-08-01 DE DE90114787T patent/DE69005557T2/de not_active Expired - Fee Related
- 1990-08-01 EP EP90114787A patent/EP0411615B1/en not_active Expired - Lifetime
- 1990-08-01 PT PT94874A patent/PT94874A/pt not_active Application Discontinuation
- 1990-08-01 KR KR1019900011931A patent/KR910004559A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| NO903384L (no) | 1991-02-04 |
| EP0411615A1 (en) | 1991-02-06 |
| EP0411615B1 (en) | 1993-12-29 |
| AU6001990A (en) | 1991-02-07 |
| CA2022510A1 (en) | 1991-02-03 |
| FI903835A0 (fi) | 1990-08-01 |
| NO903384D0 (no) | 1990-08-01 |
| ATE99290T1 (de) | 1994-01-15 |
| IE902792A1 (en) | 1991-02-27 |
| PT94874A (pt) | 1991-04-18 |
| JPH0374359A (ja) | 1991-03-28 |
| FI903835A7 (fi) | 1991-02-03 |
| KR910004559A (ko) | 1991-03-28 |
| US4988688A (en) | 1991-01-29 |
| DK0411615T3 (da) | 1994-01-24 |
| DE69005557D1 (de) | 1994-02-10 |
| ES2062220T3 (es) | 1994-12-16 |
| DE69005557T2 (de) | 1994-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ234672A (en) | N-(1,2,3,4-tetrahydro-9-acridinyl)amide and carbamate derivatives and pharmaceutical compositions | |
| AU637086B2 (en) | Use of 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in the preparation of pharmaceutical compositions in controlled- release form active in the therapy of organic mental disturbances, and the relative pharmaceutical compositions | |
| HUT61196A (en) | Process for producing pharmaceutical composition which may be dropped in the eye | |
| ZA906057B (en) | 4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents | |
| IL86423A0 (en) | Pharmaceutical compositions for the treatment of alzheimer's disease | |
| EP0267676A3 (en) | Use of 1,3-di-n-butyl-7-(2-oxypropyl) xanthine in the treatment of cerebrovascular or cerebral senility associated disorders, peripheral vascular disease and proliferative skin diseases | |
| HUP0401325A3 (en) | Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds | |
| SI9720060B (en) | Use of 2-phenyl-1, 2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease | |
| CA2301706A1 (en) | Use of phanquinone for the treatment of alzheimer's disease | |
| UA42731C2 (uk) | Арилалкілтіадіазинони, спосіб їх отримання, фармацевтична композиція, спосіб її отримання, спосіб лікування | |
| ES2009689A6 (es) | Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima. | |
| HU9201247D0 (en) | Process for the production of condensed diazepinone derivatives and of mnedical preparations containing them as active agents | |
| ZA891769B (en) | Heterocyclic compounds | |
| IL85231A0 (en) | Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,pharmaceutical compositions containing same and the use thereof | |
| EP0400916A3 (en) | 4,5,6,11-Tetrahydrobenzo [6,7]-cycloocta[1,2-b]thiophen-6,11-imines and 6,11-dihydrobenzo[6,7]-cycloocta[1,2-b]thiophen-6,11 imines | |
| IL111922A0 (en) | Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylates, their preparation and pharmaceutical com¦ositions containing them | |
| HK2794A (en) | 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| ES2008421A6 (es) | Procedimiento para la obtencion de derivados de la pilocarpina. |